Abstract
Myocardial infarction (MI) is a common disease whose pathogenesis includes genetic factors, and it is among the leading causes of death. In 2000, we started a genome-wide association study (GWAS) for MI using nearly 90,000 gene-based single-nucleotide polymorphisms (SNPs), and identified lymphotoxin-a (LTA) conferring risk of MI in Japanese population. This was the first GWAS that identified a disease susceptibility gene in the world. Moreover, through examining the LTA cascade by combination of biological and genetic analyses, we have identified additional MI-susceptible genes, LGALS2, PSMA6, and BRAP, so far. We present here our recent work focused on identification and functional analyses of genes that confer risk of MI.
This is a preview of subscription content, log in via an institution to check access.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Breslow JW. Cardiovascular disease burden increases, NIH funding decreases. Nat Med. 1997;3:600–1.
Braunwald E. Shattuck lecture – cardiovascular medicine at the turn of the millennium: triumphs, concerns and opportunities. N Engl J Med. 1997;337:1360–9.
Falk E, Shah PK, Fuster V. Coronary plaque disruption. Circulation. 1995;92:657–71.
Libby P. Molecular bases of the acute coronary syndromes. Circulation. 1995;91:2844–50.
Ross R. Atherosclerosis – an inflammatory disease. N Engl J Med. 1999;340:115–26.
Lusis AJ, Mar R, Pajukanta P. Genetics of atherosclerosis. Annu Rev Genomics Hum Genet. 2004;5:189–218.
Marenberg ME, Rish N, Berkman LF, et al. Genetic susceptibility to death from coronary heart disease in a study of twins. N Engl J Med. 1994;330:1041–6.
Lander ES. The new genomics: global views of biology. Science. 1996;274:536–9.
Risch N, Merikangas K. The future of genetic studies of complex human diseases. Science. 1996;273:1516–7.
Collins FS, Guyer MS, Charkravarti A. Variations on a theme: cataloging human DNA sequence variation. Science. 1997;278:1580–1.
Haga H, Yamada R, Ohnishi Y, et al. Gene-based SNP discovery as part of the Japanese Millennium Genome Project: identification of 190,562 genetic variations in the human genome. J Hum Genet. 2002;47:605–10.
Ohnishi Y, Tanaka T, Ozaki K, et al. A high-throughput SNP typing system for genome-wide association studies. J Hum Genet. 2001;46:471–7.
Ozaki K, Ohnishi Y, Iida A, et al. Functional SNPs in the lymphotoxin-alpha gene that are associated with susceptibility to myocardial infarction. Nat Genet. 2002;32:650–4.
Ishii N, Ozaki K, Sato H, et al. Identification of a novel non-coding RNA, MIAT, that confers risk of myocardial infarction. J Hum Genet. 2006;51:1087–99.
Ebana Y, Ozaki K, Sato H, et al. A functional SNP in ITIH3 is associated with susceptibility to myocardial infarction. J Hum Genet. 2007;52:220–9.
Ozaki K, Inoue K, Sato H, et al. Functional variation in LGALS2 confers risk of myocardial infarction and regulates lymphotoxin-alpha secretion in vitro. Nature. 2004;429:72–5.
Ozaki K, Sato H, Iida A, et al. A functional SNP in PSMA6 confers risk of myocardial infarction in the Japanese population. Nat Genet. 2006;38:921–5.
Ozaki K, Sato H, Inoue K, et al. SNPs in BRAP associated with risk of myocardial infarction in Asian populations. Nat Genet. 2009;1:329–33.
PROCARDIS Consortium. A trio family study showing association of the lymphotoxin-alpha N26 (804A) allele with coronary artery disease. Eur J Hum Genet. 2004;12:770–4.
Ozaki K, Tanaka T. Genome-wide association study to identify SNPs conferring risk of myocardial infarction and their functional analyses. Cell Mol Life Sci. 2005;62:1804–13.
Tanaka T, Ozaki K. Inflammation as a risk factor for myocardial infarction. J Hum Genet. 2006;51:595–604.
Beinke S, Ley SC. Functions of NF-kappaB1 and NF-kappaB2 in immune cell biology. Biochem J. 2004;382:393–409.
Coux O, Tanaka K, Goldberg AL. Structure and functions of the 20S and 26S proteasomes. Annu Rev Biochem. 1996;65:801–47.
International HapMap Consortium. A haplotype map of the human genome. Nature. 2005;437:1299–320.
Li S, Ku CY, Farmer AA, et al. Identification of a novel cytoplasmic protein that specifically binds to nuclear localization signal motifs. J Biol Chem. 1998;273:6183–9.
Matheny SA, Chen C, Kortum RL, et al. Ras regulates assembly of mitogenic signaling complexes through the effector protein IMP. Nature. 2004;427:256–60.
Ory S, Morrison DK. Signal transduction: implications for Ras-dependent ERK signaling. Curr Biol. 2004;14:R277–8.
O’Neill LA. Targeting signal transduction as a strategy to treat inflammatory diseases. Nat Rev Drug Discov. 2006;5:549–63.
Karin M, Delhase M. The I kappa B kinase (IKK) and NF-kappa B: key elements of proinflammatory signaling. Semin Immunol. 2000;12:85–98.
Helgadottir A, Thorleifsson G, Manolescu A, et al. A common variant on chromosome 9p21 affects the risk of myocardial infarction. Science. 2007;316:1491–3.
McPherson R, Pertsemlidis A, Kavaslar N, et al. A common allele on chromosome 9 associated with coronary artery disease. Science. 2007;316:1488–91.
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2011 Springer Science+Business Media, LLC
About this chapter
Cite this chapter
Ozaki, K., Tanaka, T. (2011). Genetic Background of Myocardial Infarction. In: Ostadal, B., Nagano, M., Dhalla, N. (eds) Genes and Cardiovascular Function. Springer, Boston, MA. https://doi.org/10.1007/978-1-4419-7207-1_12
Download citation
DOI: https://doi.org/10.1007/978-1-4419-7207-1_12
Published:
Publisher Name: Springer, Boston, MA
Print ISBN: 978-1-4419-7206-4
Online ISBN: 978-1-4419-7207-1
eBook Packages: MedicineMedicine (R0)